Abstract
The ability of azathioprine to reduce the maintenance prednisolone requirement of 31 patients with polymyalgia rheumatica (PMR) or giant cell arteritis (GCA), or both, was tested in a double-blind placebo controlled study over one year. Clinical and laboratory assessments were made at four-weekly intervals over a period of 52 weeks. A statistically significant difference (p less than 0.05) in mean prednisolone dose was noted between the two groups at the end of 52 weeks, there being a fall in steroid requirement in the azathioprine treated group.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- De Silva M., Hazleman B. L. Long-term azathioprine in rheumatoid arthritis: a double-blind study. Ann Rheum Dis. 1981 Dec;40(6):560–563. doi: 10.1136/ard.40.6.560. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hamrin B., Jonsson N., Hellsten S. "Polymyalgia arteritica". Further clinical and histopathological studies with a report of six autopsy cases. Ann Rheum Dis. 1968 Sep;27(5):397–405. doi: 10.1136/ard.27.5.397. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hazleman B. Incidence of neoplasms in patients with rheumatoid arthritis exposed to different treatment regimens. Am J Med. 1985 Jan 21;78(1A):39–43. doi: 10.1016/0002-9343(85)90244-x. [DOI] [PubMed] [Google Scholar]
- Jones J. G., Hazleman B. L. Prognosis and management of polymyalgia rheumatica. Ann Rheum Dis. 1981 Feb;40(1):1–5. doi: 10.1136/ard.40.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mason M., Currey H. L., Barnes C. G., Dunne J. F., Hazleman B. L., Strickland I. D. Azathioprine in rheumatoid arthritis. Br Med J. 1969 Feb 15;1(5641):420–422. doi: 10.1136/bmj.1.5641.420. [DOI] [PMC free article] [PubMed] [Google Scholar]